标题
A Consensus Statement on acromegaly therapeutic outcomes
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 14, Issue 9, Pages 552-561
出版商
Springer Nature America, Inc
发表日期
2018-07-26
DOI
10.1038/s41574-018-0058-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Bone microarchitecture and estimated bone strength in men with active acromegaly
- (2017) Paula P B Silva et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues
- (2017) S E Franck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry
- (2017) Luigi Maione et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Classification of Patients With GH Disorders May Vary According to the IGF-I Assay
- (2017) Maria Mavromati et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
- (2017) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Correlation between GH and IGF-1 during treatment for acromegaly
- (2017) Edward H. Oldfield et al. JOURNAL OF NEUROSURGERY
- Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors
- (2017) Harish Babu et al. NEUROSURGERY
- Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
- (2017) Aart J. van der Lely et al. Pituitary
- Biochemical investigations in diagnosis and follow up of acromegaly
- (2017) Katharina Schilbach et al. Pituitary
- Somatostatin receptor ligands in the treatment of acromegaly
- (2017) Monica R. Gadelha et al. Pituitary
- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
- (2017) Felipe F. Casanueva et al. Pituitary
- Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria
- (2017) Ihsan Anik et al. World Neurosurgery
- How to improve effectiveness of pegvisomant treatment in acromegalic patients
- (2017) M. Ragonese et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pegvisomant in acromegaly: an update
- (2017) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDY
- (2016) Aart Jan van der Lely et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis
- (2016) Nicholas A Tritos et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?
- (2016) A Muhammad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- New medical therapies of acromegaly
- (2016) F. Maffezzoni et al. GROWTH HORMONE & IGF RESEARCH
- Pituitary Medicine From Discovery to Patient-Focused Outcomes
- (2016) Shlomo Melmed JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays
- (2016) Philippe Chanson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cabergoline in acromegaly
- (2016) Emmanuelle Kuhn et al. Pituitary
- Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
- (2016) Stefano Frara et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- RADIOTHERAPY VERSUS RADIOSURGERY IN TREATING PATIENTS WITH ACROMEGALY: A SYSTEMATIC REVIEW AND META-ANALYSIS
- (2015) Abd Moain Abu Dabrh et al. Endocrine Practice
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: MANAGEMENT OF ACROMEGALY PATIENTS: WHAT IS THE ROLE OF PRE-OPERATIVE MEDICAL THERAPY?
- (2015) Maria Fleseriu et al. Endocrine Practice
- Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy
- (2015) Pamela Freda et al. Endocrine Practice
- X-linked acrogigantism syndrome: clinical profile and therapeutic responses
- (2015) A. Beckers et al. ENDOCRINE-RELATED CANCER
- Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences
- (2015) I. Potorac et al. ENDOCRINE-RELATED CANCER
- Mortality in acromegaly: a 20-year follow-up study
- (2015) Elina Ritvonen et al. ENDOCRINE-RELATED CANCER
- Pituitary Diseases and Bone
- (2015) Gherardo Mazziotti et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
- (2015) Emmanuelle Kuhn et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers
- (2015) Laura C. Hernández-Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Structural and Functional Acromegaly Classification
- (2015) Daniel Cuevas-Ramos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- (2015) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clomiphene Citrate for Treatment of Acromegaly Not Controlled by Conventional Therapies
- (2015) Felipe H. Duarte et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
- (2015) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New therapeutic agents for acromegaly
- (2015) Shlomo Melmed Nature Reviews Endocrinology
- The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
- (2015) Annamaria Colao et al. Pituitary
- SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study
- (2015) Andrea Giustina et al. Pituitary
- IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition
- (2015) Tirissa J. Reid et al. Pituitary
- Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
- (2015) Caroline Sievers et al. Pituitary
- Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Successful Mortality Reduction and Control of Comorbidities in Patients With Acromegaly Followed at a Highly Specialized Multidisciplinary Clinic
- (2014) Moises Mercado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system
- (2014) V. S. Nunes et al. Pituitary
- The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines
- (2014) K. Lois et al. Pituitary
- Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease
- (2014) Elisa Verrua et al. International Journal of Endocrinology
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Complex Rhythmicity and Age Dependence of Growth Hormone Secretion Are Preserved in Patients With Acromegaly: Further Evidence for a Present Hypothalamic Control of Pituitary Somatotropinomas
- (2013) Antônio Ribeiro-Oliveira et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
- (2013) Robert M. Starke et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Progression of Vertebral Fractures Despite Long-Term Biochemical Control of Acromegaly: A Prospective Follow-up Study
- (2013) K. M. J. A. Claessen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria
- (2013) Derya Burcu Hazer et al. JOURNAL OF NEUROSURGERY
- Long-term Changes in Serum IGF-1 Levels After Successful Surgical Treatment of Growth Hormone–Secreting Pituitary Adenoma
- (2013) Mi-Seon Shin et al. NEUROSURGERY
- Biochemical and quality of life responses to octreotide-LAR in acromegaly
- (2013) Ruth Mangupli et al. Pituitary
- Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies
- (2013) Jennifer C. Stone et al. Pituitary
- Tamoxifen as a therapeutic agent in acromegaly
- (2013) Irida Balili et al. Pituitary
- No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
- (2012) Luigi Maione et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
- (2012) Andrea Giustina et al. PLoS One
- Clinical Utility of Insulin-Like Growth Factor 1 and 2; Determination by High Resolution Mass Spectrometry
- (2012) Cory Bystrom et al. PLoS One
- Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
- (2011) D. R. Clemmons et al. CLINICAL CHEMISTRY
- High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly
- (2011) M J E Wassenaar et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
- (2011) John A. Jane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
- (2011) Jessica A. Brzana et al. Pituitary
- Clinical laboratory indices in the treatment of acromegaly
- (2010) David R. Clemmons CLINICA CHIMICA ACTA
- Mortality in Patients with Pituitary Disease
- (2010) Mark Sherlock et al. ENDOCRINE REVIEWS
- Endocrine Aspects of Obstructive Sleep Apnea
- (2010) Pierre Attal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
- (2010) Manel Puig-Domingo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control
- (2010) Christian Berg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatotroph Tumor Progression during Pegvisomant Therapy: A Clinical and Molecular Study
- (2010) M. Marazuela et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
- (2010) Troy H. Dillard et al. Pituitary
- Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
- (2009) SJCMM Neggers et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Measurement of human growth hormone by immunoassays: Current status, unsolved problems and clinical consequences
- (2009) Martin Bidlingmaier et al. GROWTH HORMONE & IGF RESEARCH
- Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly
- (2009) Antonio Bianchi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
- (2009) M. Sherlock et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly
- (2009) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study
- (2009) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Volume of Growth Hormone-Secreting Pituitary Adenomas during Treatment with Pegvisomant: A Prospective Multicenter Study
- (2009) Jan-Hendrik Buhk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review
- (2009) Gherardo Mazziotti et al. Pituitary
- Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
- (2009) Roberto Salvatori et al. Pituitary
- Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
- (2009) Shlomo Melmed et al. Pituitary
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR®
- (2008) Evelyn Oliveira Machado et al. GROWTH HORMONE & IGF RESEARCH
- A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System
- (2008) Brian A. Swiglo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
- (2008) Robert D. Murray et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence of Vertebral Fractures in Men with Acromegaly
- (2008) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial
- (2008) Sven M. Carlsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index
- (2008) Ayman M. Arafat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
- (2008) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
- (2008) Theodoros Rokkas et al. WORLD JOURNAL OF GASTROENTEROLOGY
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started